Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1389426 New York, NY
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,251,956
-$482,170 QoQ
Shares Held
613,612
-31.1% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 344 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. RXRX ranks #54 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6
33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in RXRX

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,251,956 613,612
2026-03-31 $2,734,126 890,595
2025-12-31 $3,962,449 968,814
2025-09-30 $3,660,932 750,191
2025-06-30 $1,802,215 356,169
2025-03-31 $3,165,641 598,420
2024-12-31 $4,025,390 595,472
2024-09-30 $4,453,462 675,791
2024-06-30 $3,331,830 444,244
2024-03-31 $8,875,682 890,239
2023-12-31 $10,749,105 1,090,173
2023-09-30 $8,449,623 1,104,526
2023-06-30 $2,393,485 320,413
2023-03-31 $3,001,379 449,982
2022-12-31 $4,595,676 596,067
2022-09-30 $1,835,676 172,526
2022-06-30 $1,112,135 136,626
2022-03-31 $742,126 103,649
2021-12-31 $6,768,645 395,134
2021-09-30 $1,565,163 68,021